E

Estrella Immunopharma Inc
NASDAQ:ESLA

Watchlist Manager
Estrella Immunopharma Inc
NASDAQ:ESLA
Watchlist
Price: 1.18 USD -0.84% Market Closed
Market Cap: $49.6m

Cash Flow Statement

Cash Flow Statement
Estrella Immunopharma Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(0)
(2)
(1)
(1)
(1)
(11)
(2)
(3)
(3)
(7)
(9)
(4)
(10)
(12)
(14)
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
1
0
0
2
1
1
Other Non-Cash Items
0
0
(0)
(1)
(1)
0
1
1
1
1
0
0
1
1
1
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(0)
0
0
1
1
9
1
(10)
(14)
(10)
(9)
1
6
7
10
Cash from Operating Activities
(0)
N/A
(1)
-200%
(2)
-10%
(1)
+35%
(2)
-49%
(1)
+14%
(1)
+32%
(12)
-1 229%
(16)
-33%
(16)
-1%
(18)
-12%
(3)
+83%
(4)
-24%
(4)
-3%
(3)
+37%
Investing Cash Flow
Other Items
0
0
0
36
36
(0)
36
5
5
5
5
0
0
0
0
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
36
N/A
36
+0%
(0)
N/A
36
N/A
5
-86%
5
-2%
5
0%
5
+2%
0
N/A
0
N/A
0
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
47
5
0
(36)
0
0
(27)
9
9
9
(1)
(0)
(0)
1
2
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
(1)
1
1
1
1
0
11
5
4
4
(7)
0
0
(0)
(0)
Cash from Financing Activities
46
N/A
6
-88%
1
-91%
(36)
N/A
(35)
+1%
0
N/A
(16)
N/A
14
N/A
13
-2%
13
-3%
(7)
N/A
(0)
+98%
(0)
-222%
1
N/A
2
+104%
Change in Cash
Net Change in Cash
0
N/A
4
+1 178%
(1)
N/A
(0)
+61%
(1)
-56%
(2)
-140%
20
N/A
7
-67%
2
-66%
2
-25%
(20)
N/A
(3)
+84%
(4)
-33%
(3)
+34%
(0)
+94%
Free Cash Flow
Free Cash Flow
(0)
N/A
(1)
-200%
(2)
-10%
(1)
+35%
(2)
-49%
(1)
+14%
(1)
+32%
(12)
-1 229%
(16)
-33%
(16)
-1%
(18)
-12%
(3)
+83%
(4)
-24%
(4)
-3%
(3)
+37%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett